Summary:
Midwest Research Group is conducting a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Molindone Hydrochloride Extended-Release Tablets for the Treatment of Impulsive Aggression in Pediatric Patients with Attention Deficit/Hyperactivity Disorder (ADHD) in Conjunction with Standard ADHD Treatment.
Qualified Participants Must:
• Be between 6 to 12 years of age
•
Be diagnosed with ADHD
•
Currently be taking a medicine for ADHD
Qualified Participants May Receive:
Study medication at no cost, Psychiatric evaluation, and Compensation for time/travel